Eli Lilly’s AI collaborations via TuneLab cut preclinical timelines by up to 30% and reduce attrition rates, democratizing drug discovery for smaller firms with enhanced data privacy. Eli Lilly&...
Artificial intelligence is accelerating drug discovery for rare diseases, reducing costs by up to 50% and shortening timelines, enabling bespoke therapies and improving healthcare equity globally. AI ...
Artificial intelligence is transforming healthcare by enabling bespoke treatments for rare diseases, reducing drug development costs, and raising ethical questions, as shown in recent studies and regu...
Explore how Ayurveda’s ethnopharmacology inspires novel drug discoveries and precise therapies by harnessing medicinal plants for minimal side effects. Traditional Ayurveda paves the way for mod...
